Cutler Group LP Fusion Pharmaceuticals Inc. Call Options Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 Apr 19, 2024	BUY	$7.9 - $21.32 $3,950 - $10,660	500 Added 55.56%	1,400 $1,000
Q4 2023 Jan 18, 2024	BUY	$2.48 - $9.65 $2,232 - $8,685	900 New	900 $1,000
Q4 2021 Jan 18, 2022	SELL	$4.17 - $7.78 $3,336 - $6,224	-800 Closed	0 $0
Q3 2021 Oct 26, 2021	SELL	$7.83 - $9.41 $1,566 - $1,882	-200 Reduced 20.0%	800 $0
Q2 2021 Jul 19, 2021	BUY	$7.97 - $10.66 $7,970 - $10,660	1,000 New	1,000 $0

93K

1.4K

Ticker FUSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,390,500
Description
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.